๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Model for end-stage liver disease (MELD) and allocation of donor livers

โœ Scribed by Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M. Merion; Robert A. Wolfe; Ruud Krom

Book ID
119756902
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
100 KB
Volume
124
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The model for end-stage liver disease (M
The model for end-stage liver disease (MELD)
โœ Patrick S. Kamath; W. Ray Kim ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 1 views

The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an

Model for end-stage liver disease (MELD)
Model for end-stage liver disease (MELD) exception for polycystic liver disease
โœ Luis Arrazola; Dilip Moonka; Robert G. Gish; Gregory T. Everson ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB

Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh